In this work, we demonstrated that the excited poly[4,8-bis(5-(2-ethylhexyl)thiophen-2-yl)benzo[1,2-b;4,5-b']dithiophene-2,6-diyl-alt-(4-(2-ethylhexyl)-3-fluorothieno[3,4-b]thiophene-)-2-carboxylate-2,6-diyl)] (PTB7-Th) will be degraded by [6,6]-phenyl-C-butyric acid methyl ester (PCBM) or photolysis fragment of 1,8-diiodooctane (DIO) in the presence of oxygen and under irradiation of red light. From the previous reports, the fragment of DIO may be involved in the reaction directly. Our work indicates the PCBM is not directly involved in the reaction, but is acting as a catalyst to promote the reaction of excited donors with oxygen. Thus, PTB7-Th urgently needs a kind of nonresidual iodine-free additive to replace DIO and remove the fullerene from the donor phase at the same time. Taking into consideration PCBM solubility and boiling point difference between solvent additives and host solvents, 1,4-butanedithiol solvent was selected to fabricate PTB7-Th:PCBM-based solar cells achieving a best power conversion efficiency (PCE) of 10.2% (8.5% for PTB7:PCBM). Iodine-free butanedithiol can not only avoid excited polymer reacting with the photolysis fragment of DIO but also suppress the degradation of the excited PTB7-Th caused by synergistic effect between the fullerene and oxygen via extracting the free/trapped PCBM from the donor phase. Eventually, the film prepared with 1,4-butanedithiol shows higher stability than the film prepared without any additives and much better than the film with DIO in macro-/micromorphology, light absorption, and device performance.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acsami.6b16538 | DOI Listing |
Fertil Steril
December 2024
Section of Obstetrics and Gynecology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy. Electronic address:
Objective: To demonstrate the "cold loop technique" for the hysteroscopic treatment of FIGO type 3 myomas.
Design: Step-by-step demonstration of the technique using educative video.
Subject: A 45-year-old infertile patient with repeated oocyte donor IVF failures affected by a FIGO type 3 myoma.
Med
December 2024
Nuffield Department of Surgical Sciences, University of Oxford, Oxford OX3 9DU, UK. Electronic address:
Background: Adoptive transfer of autologous regulatory T cells (Tregs) is a promising therapeutic strategy aimed at enabling immunosuppression minimization following kidney transplantation. In our phase 1 clinical trial of Treg therapy in living donor renal transplantation, the ONE Study (ClinicalTrials.gov: NCT02129881), we observed focal lymphocytic infiltrates in protocol kidney transplant biopsies that are not regularly seen in biopsies of patients receiving standard immunosuppression.
View Article and Find Full Text PDFSci Rep
December 2024
Complete Fertility, Princess Anne Hospital, Level F, Coxford Road, Southampton, SO16 5YA, UK.
Elevated progesterone (EP) or inadequate progesterone levels during ART cycle monitoring may lead to cycle cancellations or further progesterone supplementation, but practice varies. It remains controversial whether modifying clinical practice in the presence or absence of EP improves clinical outcomes. This systematic review aims to investigate if progesterone levels at different phases of fresh and frozen ART cycles influence pregnancy outcomes, in particular, that pertaining to day 3 versus day 5 embryo transfers.
View Article and Find Full Text PDFJ Neurosurg
December 2024
Departments of1Neurosurgery.
Objective: Periventricular anastomosis (PA), a recently recognized cause of hemorrhage in moyamoya disease, is reducible after bypass surgery. The timing of the reduction, however, remains poorly understood. The objectives of the present study were to demonstrate radiological reduction of PA occurring within 48 hours after surgery and to identify factors associated with reduction.
View Article and Find Full Text PDFHum Reprod
December 2024
Assisted Reproduction Center, Northwest Women's and Children's Hospital, Xi'an, China.
Study Question: Are live birth rates (LBRs) per woman following flexible progestin-primed ovarian stimulation (fPPOS) treatment non-inferior to LBRs per woman following the conventional GnRH-antagonist protocol in expected suboptimal responders undergoing freeze-all cycles in assisted reproduction treatment?
Summary Answer: In women expected to have a suboptimal response, the 12-month likelihood of live birth with the fPPOS treatment did not achieve the non-inferiority criteria when compared to the standard GnRH antagonist protocol for IVF/ICSI treatment with a freeze-all strategy.
What Is Known Already: The standard PPOS protocol is effective for ovarian stimulation, where medroxyprogesterone acetate (MPA) is conventionally administered in the early follicular phase for ovulatory suppression. Recent retrospective cohort studies on donor cycles have shown the potential to prevent premature ovulation and maintain oocyte yields by delaying the administration of MPA until the midcycle (referred to as fPPOS), similar to GnRH antagonist injections.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!